Perrigo Company (PRGO)
-NYSE 121.16 
1.65(1.38%) 04:04 SGT|After Hours
:
121.16 0.00 (0.00%) 05:27 SGT
| Prev Close: | 119.51 |
|---|
| Open: | 119.47 |
|---|
| Bid: | 114.40 x 100 |
|---|
| Ask: | 121.22 x 500 |
|---|
| 1y Target Est: | 126.31 |
|---|
| Beta: | 0.14 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 119.44 - 121.30 |
|---|
| 52wk Range: | 98.79 - 121.33 |
|---|
| Volume: | 502,364 |
|---|
| Avg Vol (3m): | 584,194 |
|---|
| Market Cap: | 11.39B |
|---|
| P/E (ttm): | 26.05 |
|---|
| EPS (ttm): | 4.65 |
|---|
| Div & Yield: | 0.36 (0.30%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Perrigo in Expansion ModeZacks(Tue, 18 Jun)
- Perrigo acquires eye-care portfolio from FeraAP(Mon, 17 Jun)
- Perrigo acquires eye-care portfolio from FeraAP(Mon, 17 Jun)
- InPlay: Perrigo acquires ophthalmic product portfolio from Fera Pharmaceuticals for an upfront payment of $93 mln; expected to be more than $0.12 accretive to adjusted EPS for fiscal 2014Briefing.com(Mon, 17 Jun)
- Perrigo acquires ophthalmic product portfolio from Fera for $93Mtheflyonthewall.com(Mon, 17 Jun)
- Perrigo begins trading on NYSEAP(Fri, 7 Jun)
- Sector Snap: Makers of morning-after pill riseAP(Fri, 7 Jun)
- Netflix to join the Nasdaq-100 index next weekAP(Fri, 31 May)
- Perrigo seeks approval of generic AxironAP(Wed, 29 May)
- Perrigo to transfer stock to NYSEAP(Thu, 23 May)
Key Statistics
| Forward P/E (1 yr): | 18.41 |
|---|
| P/S (ttm): | 3.30 |
|---|
| Ex-Dividend Date: | 29-May-13 |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 5.62 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.57 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 1.79 |
|---|
Business Summary
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide.
View More